ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis
FRA:EUZ - Deutsche Boerse Ag - DE0005659700 - Common Stock - Currency: EUR
Taking everything into account, EUZ scores 7 out of 10 in our fundamental rating. EUZ was compared to 57 industry peers in the Health Care Equipment & Supplies industry. EUZ gets an excellent profitability rating and is at the same time showing great financial health properties. EUZ is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make EUZ suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year EUZ was profitable.
In the past year EUZ had a positive cash flow from operations.
Each year in the past 5 years EUZ has been profitable.
Each year in the past 5 years EUZ had a positive operating cash flow.
1.2 Ratios
EUZ has a Return On Assets of 7.63%. This is amongst the best in the industry. EUZ outperforms 80.36% of its industry peers.
The Return On Equity of EUZ (14.94%) is better than 82.14% of its industry peers.
EUZ has a better Return On Invested Capital (12.03%) than 91.07% of its industry peers.
EUZ had an Average Return On Invested Capital over the past 3 years of 9.92%. This is in line with the industry average of 8.20%.
The 3 year average ROIC (9.92%) for EUZ is below the current ROIC(12.03%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 14.94% | ||
| ROIC | 12.03% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
1.3 Margins
The Profit Margin of EUZ (11.63%) is better than 78.57% of its industry peers.
EUZ's Profit Margin has declined in the last couple of years.
The Operating Margin of EUZ (21.36%) is better than 87.50% of its industry peers.
EUZ's Operating Margin has improved in the last couple of years.
The Gross Margin of EUZ (47.98%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of EUZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.36% | ||
| PM (TTM) | 11.63% | ||
| GM | 47.98% |
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
EUZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
EUZ has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, EUZ has more shares outstanding
Compared to 1 year ago, EUZ has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.83 indicates that EUZ is not in any danger for bankruptcy at the moment.
EUZ has a Altman-Z score of 5.83. This is amongst the best in the industry. EUZ outperforms 82.14% of its industry peers.
The Debt to FCF ratio of EUZ is 1.02, which is an excellent value as it means it would take EUZ, only 1.02 years of fcf income to pay off all of its debts.
EUZ has a better Debt to FCF ratio (1.02) than 89.29% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that EUZ is not too dependend on debt financing.
EUZ's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. EUZ outperforms 69.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.02 | ||
| Altman-Z | 5.83 |
ROIC/WACC1.74
WACC6.92%
2.3 Liquidity
A Current Ratio of 3.08 indicates that EUZ has no problem at all paying its short term obligations.
EUZ's Current ratio of 3.08 is fine compared to the rest of the industry. EUZ outperforms 78.57% of its industry peers.
EUZ has a Quick Ratio of 2.46. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.46, EUZ belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.08 | ||
| Quick Ratio | 2.46 |
3. Growth
3.1 Past
EUZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.59%, which is quite good.
Measured over the past years, EUZ shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.20% on average per year.
Looking at the last year, EUZ shows a quite strong growth in Revenue. The Revenue has grown by 15.89% in the last year.
EUZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.63% yearly.
EPS 1Y (TTM)14.59%
EPS 3Y-1.5%
EPS 5Y8.2%
EPS Q2Q%15.88%
Revenue 1Y (TTM)15.89%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%0.85%
3.2 Future
Based on estimates for the next years, EUZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.72% on average per year.
Based on estimates for the next years, EUZ will show a quite strong growth in Revenue. The Revenue will grow by 9.18% on average per year.
EPS Next Y25%
EPS Next 2Y17.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.94%
Revenue Next 2Y9.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 37.91, EUZ can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as EUZ.
EUZ's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.82.
Based on the Price/Forward Earnings ratio of 24.00, the valuation of EUZ can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as EUZ.
EUZ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.21.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.91 | ||
| Fwd PE | 24 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EUZ is valued a bit cheaper than 64.29% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EUZ indicates a somewhat cheap valuation: EUZ is cheaper than 73.21% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.08 | ||
| EV/EBITDA | 16.39 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
EUZ has an outstanding profitability rating, which may justify a higher PE ratio.
EUZ's earnings are expected to grow with 17.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.52
PEG (5Y)4.63
EPS Next 2Y17.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a yearly dividend of 0.75%, EUZ is not a good candidate for dividend investing.
EUZ's Dividend Yield is comparable with the industry average which is at 2.28.
Compared to an average S&P500 Dividend Yield of 2.39, EUZ's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
5.2 History
The dividend of EUZ decreases each year by -30.23%.
Dividend Growth(5Y)-30.23%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
3.02% of the earnings are spent on dividend by EUZ. This is a low number and sustainable payout ratio.
DP3.02%
EPS Next 2Y17.72%
EPS Next 3YN/A
FRA:EUZ (8/1/2025, 7:00:00 PM)
61.8
-4.9 (-7.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.96%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap1.31B
Analysts80
Price Target68.9 (11.49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
Yearly Dividend0.05
Dividend Growth(5Y)-30.23%
DP3.02%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.91 | ||
| Fwd PE | 24 | ||
| P/S | 4.41 | ||
| P/FCF | 25.08 | ||
| P/OCF | 18.71 | ||
| P/B | 5.67 | ||
| P/tB | 7.19 | ||
| EV/EBITDA | 16.39 |
EPS(TTM)1.63
EY2.64%
EPS(NY)2.58
Fwd EY4.17%
FCF(TTM)2.46
FCFY3.99%
OCF(TTM)3.3
OCFY5.35%
SpS14
BVpS10.9
TBVpS8.6
PEG (NY)1.52
PEG (5Y)4.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 14.94% | ||
| ROCE | 16.94% | ||
| ROIC | 12.03% | ||
| ROICexc | 17.6% | ||
| ROICexgc | 21.76% | ||
| OM | 21.36% | ||
| PM (TTM) | 11.63% | ||
| GM | 47.98% | ||
| FCFM | 17.6% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
ROICexc(3y)13.44%
ROICexc(5y)13%
ROICexgc(3y)17.78%
ROICexgc(5y)17.59%
ROCE(3y)13.96%
ROCE(5y)12.89%
ROICexcg growth 3Y11.22%
ROICexcg growth 5Y1.55%
ROICexc growth 3Y17.53%
ROICexc growth 5Y5.68%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
F-Score7
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.02 | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 94.14% | ||
| Cap/Sales | 5.99% | ||
| Interest Coverage | 59.68 | ||
| Cash Conversion | 85.09% | ||
| Profit Quality | 151.32% | ||
| Current Ratio | 3.08 | ||
| Quick Ratio | 2.46 | ||
| Altman-Z | 5.83 |
F-Score7
WACC6.92%
ROIC/WACC1.74
Cap/Depr(3y)190.39%
Cap/Depr(5y)187.58%
Cap/Sales(3y)10.17%
Cap/Sales(5y)10.1%
Profit Quality(3y)67.54%
Profit Quality(5y)69.62%
High Growth Momentum
Growth
EPS 1Y (TTM)14.59%
EPS 3Y-1.5%
EPS 5Y8.2%
EPS Q2Q%15.88%
EPS Next Y25%
EPS Next 2Y17.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.89%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%0.85%
Revenue Next Year8.94%
Revenue Next 2Y9.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.39%
EBIT growth 3Y28.59%
EBIT growth 5Y16.95%
EBIT Next Year57.03%
EBIT Next 3Y19.41%
EBIT Next 5YN/A
FCF growth 1Y989.46%
FCF growth 3Y114.55%
FCF growth 5Y8.28%
OCF growth 1Y101.64%
OCF growth 3Y25.28%
OCF growth 5Y10.49%